62nd Annual Meeting

October 26 - 31, 2015

Institute 1 (ticket)

Advanced Child and Adolescent Psychopharmacology With Relevance to Primary Care Consultation

The interaction between child and adolescent psychiatrists and primary care clinicians is becoming increasingly important, especially with the advent of the medical home. This Institute provides a state-of-the-art review of current psychotropic medications and treatment strategies, providing an update on what is new in evidence-based psychopharmacologic treatments of common child and adolescent psychiatric disorders…but it does not stop there! At the end of each presentation, the discussant brings a particular focus on the clinical pearls of the presentation that are useful to share in consultation with primary care clinicians who have different expertise from child and adolescent psychiatrists. There is an emphasis on what is relevant to primary care and what is not, and how one might decide which conditions to help the primary care physician treat, and those that should be referred to the child and adolescent psychiatrist.